http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009257914-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0159e45b0a2bf82546ca446bdc5b1e42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d76052c9d22f36f29998a2cb269d4424
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L2-20
filingDate 2008-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6655a9ccf8a15025c57cd1a1393c998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5201880bb5cda31cedcc7fc296075ef
publicationDate 2009-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009257914-A1
titleOfInvention Combined use of an alkaline earth metal compound and a sterilizing agent to maintain osteoinduction properties of a demineralized bone matrix
abstract A method is disclosed that produces allografts from matrices typically containing demineralized bone matrix (DBM) powder, demineralized bone matrix gel, demineralized bone matrix paste, bone cement, cancellous bone, or cortical bone and mixtures thereof. The matrices are sterilized utilizing supercritical CO 2 in the presence of a sterilizing additive and an entrainer such as an alkaline earth metal compound, preferably CaCO 3 . The resultant allograft materials have a reduced rate of rejection when used in allograft procedures including, bone, cartilage, tendon, and ligament grafting procedures.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11246807-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015366524-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019010467-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012060991-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012060991-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8926710-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018527047-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2469205-A
priorityDate 2008-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7108832-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7638103-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7192553-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6585
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448915161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128375819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15240839

Total number of triples: 40.